Ariad Pharmaceuticals Inc fka ARIA

[BTH]

That sounds like a big waste of Merck's money if they don't see an endgame where that marketing department with rich expertise in ARIA's catalogue devolves into Merck.

Yeah.
The Harv is basically taking Merck's money and funding a sales-team for Ponatinib with it. I know the co-promotion deal has NOTHING to do with the drug Ponatinib, but, it sounds to me like Berger is doing this to build the sales offices/personnel for Ponatinib, and just using Ridaforolimus as a "test" build...all on Merck's dime.

Fine with me.

Screw Merck. Big-pharma are a-holes and I'm glad to see them footing the bill for this, inadvertently or not.